Citations to this article
Hannah G. Kelly, … , Stephen J. Kent, Adam K. Wheatley
Published May 21, 2020
Citation Information: JCI Insight. 2020;5(10):e136653. https://doi.org/10.1172/jci.insight.136653.
Citation Information: JCI Insight. 2020;5(10):e136653. https://doi.org/10.1172/jci.insight.136653.
Abstract
Protein-based, self-assembling nanoparticles elicit superior immunity compared with soluble protein vaccines, but the immune mechanisms underpinning this effect remain poorly defined. Here, we investigated the immunogenicity of a prototypic ferritin-based nanoparticle displaying influenza hemagglutinin (HA) in mice and macaques. Vaccination of mice with HA-ferritin nanoparticles elicited higher serum antibody titers and greater protection against experimental influenza challenge compared with soluble HA protein. Germinal centers in the draining lymph nodes were expanded and persistent following HA-ferritin vaccination, with greater deposition of antigen that colocalized with follicular dendritic cells. Our findings suggest that a highly ordered and repetitive antigen array may directly drive germinal centers through a B cell–intrinsic mechanism that does not rely on ferritin-specific T follicular helper cells. In contrast to mice, enhanced immunogenicity of HA-ferritin was not observed in pigtail macaques, where antibody titers and lymph node immunity were comparable to soluble vaccination. An improved understanding of factors that drive nanoparticle vaccine immunogenicity in small and large animal models will facilitate the clinical development of nanoparticle vaccines for broad and durable protection against diverse pathogens.
Authors
Hannah G. Kelly, Hyon-Xhi Tan, Jennifer A. Juno, Robyn Esterbauer, Yi Ju, Wenbo Jiang, Verena C. Wimmer, Brigette C. Duckworth, Joanna R. Groom, Frank Caruso, Masaru Kanekiyo, Stephen J. Kent, Adam K. Wheatley
Citation information
Citations to this article (51)
| Title and authors | Publication | Year |
|---|---|---|
|
A Ferritin-Based Eg95 Nanoparticle Vaccine Adjuvanted with pCpG Eliciting Robust Immune Responses Against Cystic Echinococcosis in Mice Model
Gao X, Zhu X, Liu X, Zhou C, Shang Y, Wu T, Jia H, Zhang Z, Li Y, Xin T |
International Journal of Nanomedicine | 2025 |
|
Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
Zhao Y, Liu J, Peng C, Guo S, Wang B, Chen L, Wang Y, Tang H, Liu L, Pan Q, Li S, Wang J, Yang D, Du E |
Journal of Nanobiotechnology | 2025 |
|
Adjuvant-free, self−assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses
Zhao Y, Guo S, Liu J, Wang Y, Wang B, Peng C, Du E |
Frontiers in Immunology | 2025 |
|
Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine design.
Vernhes E, Larbi Chérif L, Ducrot N, Vanbergue C, Ouldali M, Zig L, Sidibe N, Hoos S, Ramirez-Chamorro L, Renouard M, Rossier O, England P, Schoehn G, Boulanger P, Benihoud K |
npj Vaccines | 2024 |
|
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Sankhala RS, Lal KG, Jensen JL, Dussupt V, Mendez-Rivera L, Bai H, Wieczorek L, Mayer SV, Zemil M, Wagner DA, Townsley SM, Hajduczki A, Chang WC, Chen WH, Donofrio GC, Jian N, King HA, Lorang CG, Martinez EJ, Rees PA, Peterson CE, Schmidt F, Hart TJ, Duso DK, Kummer LW, Casey SP, Williams JK, Kannan S, Slike BM, Smith L, Swafford I, Thomas PV, Tran U, Currier JR, Bolton DL, Davidson E, Doranz BJ, Hatziioannou T, Bieniasz PD, Paquin-Proulx D, Reiley WW, Rolland M, Sullivan NJ, Vasan S, Collins ND, Modjarrad K, Gromowski GD, Polonis VR, Michael NL, Krebs SJ, Joyce MG |
Nature Communications | 2024 |
|
Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development
Kim D, Lai CJ, Cha I, Jung JU |
Viruses | 2024 |
|
Double-layered N-S1 protein nanoparticle immunization elicits robust cellular immune and broad antibody responses against SARS-CoV-2
Li R, Chang Z, Liu H, Wang Y, Li M, Chen Y, Fan L, Wang S, Sun X, Liu S, Cheng A, Ding P, Zhang G |
Journal of nanobiotechnology | 2024 |
|
A ferritin nanoparticle vaccine based on the hemagglutinin extracellular domain of swine influenza A (H1N1) virus elicits protective immune responses in mice and pigs
Tang P, Cui E, Cheng J, Li B, Tao J, Shi Y, Jiao J, Du E, Wang J, Liu H |
Frontiers in immunology | 2024 |
|
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Shepherd BL, Scott PT, Hutter JN, Lee C, McCauley MD, Guzman I, Bryant C, McGuire S, Kennedy J, Chen WH, Hajduczki A, Mdluli T, Valencia-Ruiz A, Amare MF, Matyas GR, Rao M, Rolland M, Mascola JR, De Rosa SC, McElrath MJ, Montefiori DC, Serebryannyy L, McDermott AB, Peel SA, Collins ND, Joyce MG, Robb ML, Michael NL, Vasan S, Modjarrad K |
2024 | |
|
Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses
Pandey KK, Sahoo BR, Pattnaik AK |
Viruses | 2024 |
|
Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia
Fang Q, Lu X, Zhu Y, Lv X, Yu F, Ma X, Liu B, Zhang H |
Cell reports. Medicine | 2024 |
|
Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice.
Karaaslan E, Sorvillo TE, Scholte FEM, O'Neal TJ, Welch SR, Davies KA, Coleman-McCray JD, Harmon JR, Ritter JM, Pegan SD, Montgomery JM, Spengler JR, Spiropoulou CF, Bergeron É |
npj Vaccines | 2024 |
|
Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response
Bhagchandani SH, Yang L, Lam JH, Maiorino L, Ben-Akiva E, Rodrigues KA, Romanov A, Suh H, Aung A, Wu S, Wadhera A, Chakraborty AK, Irvine DJ |
Science immunology | 2024 |
|
Ferritin Vaccine Platform for Animal and Zoonotic Viruses
Ahmadivand S, Fux R, Palić D |
Vaccines | 2024 |
|
Rationally designed multimeric nanovaccines using icosahedral DNA origami for display of SARS-CoV-2 receptor binding domain
Feng Q, Cheng K, Zhang L, Wang D, Gao X, Liang J, Liu G, Ma N, Xu C, Tang M, Chen L, Wang X, Ma X, Zou J, Shi Q, Du P, Wang Q, Wang H, Nie G, Zhao X |
Nature Communications | 2024 |
|
Chikungunya virus E2 B domain nanoparticle immunogen elicits homotypic neutralizing antibody in mice
Tong K, Hernandez EM, Basore K, Fremont DH, Lai JR |
Vaccine | 2024 |
|
Phenotypic and functional characterization of pharmacologically expanded Vγ9Vδ2 T cells in pigtail macaques
Barber-Axthelm IM, Wragg KM, Esterbauer R, Amarasena TH, Barber-Axthelm VR, Wheatley AK, Gibbon AM, Kent SJ, Juno JA |
iScience | 2023 |
|
A tetravalent nanoparticle vaccine elicits a balanced and potent immune response against dengue viruses without inducing antibody-dependent enhancement
Chen Q, Li R, Wu B, Zhang X, Zhang H, Chen R |
Frontiers in immunology | 2023 |
|
Recombinant ferritins for multimodal nanomedicine
Li Y, Gao H, Nepovimova E, Wu Q, Adam V, Kuca K |
Journal of Enzyme Inhibition and Medicinal Chemistry | 2023 |
|
Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie Bandavirus in aged ferrets
Kim D, Kim E, Kim S, Chung Y, Lai CJ, Cha I, Cho SD, Choi Y, Dai X, Kim S, Kang S, Kwak MJ, Liu Z, Choi Y, Park SH, Choi YK, Jung JU |
2023 | |
|
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Purcell RA, Theisen RM, Arnold KB, Chung AW, Selva KJ |
Frontiers in immunology | 2023 |
|
Progress in nanoparticle-based regulation of immune cells
Fan YN, Zhao G, Zhang Y, Ye QN, Sun YQ, Shen S, Liu Y, Xu CF, Wang J |
2023 | |
|
A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response
Song J, Wang M, Zhou L, Tian P, Sun Z, Sun J, Wang X, Zhuang G, Jiang D, Wu Y, Zhang G |
Journal of nanobiotechnology | 2023 |
|
Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie bandavirus in aged ferrets
Kim D, Kim E, Kim S, Chung Y, Lai CJ, Cha I, Cho SD, Choi Y, Dai X, Kim S, Kang S, Kwak MJ, Liu Z, Choi Y, Park SH, Choi YK, Jung JU |
mBio | 2023 |
|
Engineered Ferritin Nanoparticle Vaccines Enable Rapid Screening of Antibody Functionalization to Boost Immune Responses.
Vu MN, Pilkington EH, Lee WS, Tan HX, Davis TP, Truong NP, Kent SJ, Wheatley AK |
Advanced healthcare materials | 2023 |
|
Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate
Ávalos I, Lao T, Rodríguez EM, Zamora Y, Rodríguez A, Ramón A, Lemos G, Cabrales A, Bequet-Romero M, Casillas D, Andújar I, Espinosa LA, González LJ, Alvarez Y, Carpio Y, Estrada MP |
Human vaccines | 2022 |
|
Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases.
Tariq H, Batool S, Asif S, Ali M, Abbasi BH |
Frontiers in microbiology | 2022 |
|
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines.
Nelson SA, Richards KA, Glover MA, Chaves FA, Crank MC, Graham BS, Kanekiyo M, Sant AJ |
npj Vaccines | 2022 |
|
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens.
Kraft JC, Pham MN, Shehata L, Brinkkemper M, Boyoglu-Barnum S, Sprouse KR, Walls AC, Cheng S, Murphy M, Pettie D, Ahlrichs M, Sydeman C, Johnson M, Blackstone A, Ellis D, Ravichandran R, Fiala B, Wrenn S, Miranda M, Sliepen K, Brouwer PJM, Antanasijevic A, Veesler D, Ward AB, Kanekiyo M, Pepper M, Sanders RW, King NP |
Cell reports. Medicine | 2022 |
|
Human lymphoid tissue sampling for vaccinology
Kwiatkowska KM, Mkindi CG, Nielsen CM |
Frontiers in immunology | 2022 |
|
Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses
Qiao Y, Zhan Y, Zhang Y, Deng J, Chen A, Liu B, Zhang Y, Pan T, Zhang W, Zhang H, He X |
Frontiers in immunology | 2022 |
|
Layered Protein Nanoparticles Containing Influenza B HA stalk Inducted Sustained Cross-Protection against Viruses Spanning Both Viral Lineages
Song Y, Zhu W, Wang Y, Deng L, Ma Y, Dong C, Gonzalez GX, Kim J, Wei L, Kang SM, Wang BZ |
Biomaterials | 2022 |
|
Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines
M Sangesland, D Lingwood |
Human vaccines | 2021 |
|
Mechanisms of regulate gene expression during immune cell differentiation and development: Conversations that count: Cellular interactions that drive T cell fate
BC Duckworth, JR Groom |
Immunological Reviews | 2021 |
|
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
PJ Brouwer, A Antanasijevic, M de Gast, JD Allen, TP Bijl, A Yasmeen, R Ravichandran, JA Burger, G Ozorowski, JL Torres, C LaBranche, DC Montefiori, RP Ringe, MJ van Gils, JP Moore, PJ Klasse, M Crispin, NP King, AB Ward, RW Sanders |
npj Vaccines | 2021 |
|
Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity
MN Vu, HG Kelly, HX Tan, JA Juno, R Esterbauer, TP Davis, NP Truong, AK Wheatley, SJ Kent |
Advanced Healthcare Materials | 2021 |
|
Current and future nanoparticle vaccines for COVID-19
MN Vu, HG Kelly, SJ Kent, AK Wheatley |
EBioMedicine | 2021 |
|
Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets
YI Kim, D Kim, KM Yu, HD Seo, SA Lee, MA Casel, SG Jang, S Kim, WR Jung, CJ Lai, YK Choi, JU Jung, P Palese |
mBio | 2021 |
|
Protein-Based Nanoparticle Vaccines for SARS-CoV-2
HD Sung, N Kim, Y Lee, EJ Lee |
International journal of molecular sciences | 2021 |
|
Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
HX Tan, JA Juno, WS Lee, I Barber-Axthelm, HG Kelly, KM Wragg, R Esterbauer, T Amarasena, FL Mordant, K Subbarao, SJ Kent, AK Wheatley |
Nature Communications | 2021 |
|
A Self-Assembling Ferritin Nanoplatform for Designing Classical Swine Fever Vaccine: Elicitation of Potent Neutralizing Antibody
Z Zhao, X Chen, Y Chen, H Li, K Fang, H Chen, X Li, P Qian |
Human vaccines | 2021 |
|
Screening and development of monoclonal antibodies for identification of ferret T follicular helper cells
W Jiang, J Wong, HX Tan, HG Kelly, PG Whitney, I Barr, DS Layton, SJ Kent, AK Wheatley, JA Juno |
Scientific Reports | 2021 |
|
Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers
K Sliepen, E Schermer, I Bontjer, JA Burger, RF Lévai, P Mundsperger, PJ Brouwer, M Tolazzi, A Farsang, D Katinger, JP Moore, G Scarlatti, RJ Shattock, QJ Sattentau, RW Sanders |
npj Vaccines | 2021 |
|
Functionalizing Ferritin Nanoparticles for Vaccine Development
MQ Rodrigues, PM Alves, A Roldão |
Pharmaceutics | 2021 |
|
Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
PJ Schreur, M Tacken, B Gutjahr, M Keller, L van Keulen, J Kant, S van de Water, Y Lin, M Eiden, M Rissmann, F von Arnim, R König, A Brix, C Charreyre, JC Audonnet, MH Groschup, J Kortekaas |
Human vaccines | 2021 |
|
In Silico Analysis of the Longevity and Timeline of Individual Germinal Center Reactions in a Primary Immune Response
T Arulraj, SC Binder, M Meyer-Hermann |
Cells | 2021 |
|
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
MG Joyce, WH Chen, RS Sankhala, A Hajduczki, PV Thomas, M Choe, EJ Martinez, WC Chang, CE Peterson, EB Morrison, C Smith, RE Chen, A Ahmed, L Wieczorek, A Anderson, JB Case, Y Li, T Oertel, L Rosado, A Ganesh, C Whalen, JM Carmen, L Mendez-Rivera, CP Karch, N Gohain, Z Villar, D McCurdy, Z Beck, J Kim, S Shrivastava, O Jobe, V Dussupt, S Molnar, U Tran, CB Kannadka, S Soman, C Kuklis, M Zemil, H Khanh, W Wu, MA Cole, DK Duso, LW Kummer, TJ Lang, SE Muncil, JR Currier, SJ Krebs, VR Polonis, S Rajan, PM McTamney, MT Esser, WW Reiley, M Rolland, N de Val, MS Diamond, GD Gromowski, GR Matyas, M Rao, NL Michael, K Modjarrad |
Cell Reports | 2021 |
|
Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats
Dong C, Wang BZ |
2021 | |
|
Development of spike receptor-binding domain nanoparticle as a vaccine candidate against SARS-CoV-2 infection in ferrets
Kim YI, Kim D, Yu KM, Seo HD, Lee SA, Casel MA, Jang SG, Kim S, Jung W, Lai CJ, Choi YK, Jung JU |
2021 | |
|
Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem
W Jiang, EH Pilkington, HG Kelly, HX Tan, JA Juno, AK Wheatley, SJ Kent, VC Huber |
PloS one | 2020 |
|
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
X Ma, F Zou, F Yu, R Li, Y Yuan, Y Zhang, X Zhang, J Deng, T Chen, Z Song, Y Qiao, Y Zhan, J Liu, J Zhang, X Zhang, Z Peng, Y Li, Y Lin, L Liang, G Wang, Y Chen, Q Chen, T Pan, X He, H Zhang |
Immunity | 2020 |
